A randomised trial for the treatment of AL amyloidosis with the high dose Green Tea Extract.
Phase 2
- Conditions
- ligh chain amyloidosis
- Registration Number
- JPRN-UMIN000019732
- Lead Sponsor
- Japanese Red Cross Medical Center, Division of Hematology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1.Age less than 20 years. 2.Not able to visit Japanese Red Cross Medical Center every 3 months. 3.History of any hypersensitivity or allergic reactions to the green tea ingredients.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method compare the 3 and 6 month change in each organ involvement such as cardiac troponin T, NT-proBNP, interventricular septum thickness, ejection fraction, quantitative immunoglobulins, serum beta2 microglobulin, serum-free light chains, urinary albumin, derivatives of reactive oxygen metabolites, and biochemical antioxidant potential.
- Secondary Outcome Measures
Name Time Method